Hirobumi Tokuyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hirobumi Tokuyama has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Itoh
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
6 shared publications- Koichi Hayashi
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
6 shared publications - Shu Wakino
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
6 shared publications - Kazuhiro Hasegawa
Division of Nephrology, Department of Internal Medicine, Tokushima University School of Medicine, Tokushima-shi 770-8503, Tokushima, Japan
4 shared publications - Shu Wakino
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
3 shared publications - Takeshi Kanda
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
3 shared publications
Latest Publications
- Open Access
Ghrelin Promotes Lipid Uptake into White Adipose Tissue via Endothelial Growth Hormone Secretagogue-Receptor in Mice
Background/Objectives: Endothelial peroxisome proliferator-activated receptor gamma (PPARγ) regulates adipose tissue by facilitating lipid uptake into white adipocytes, but the role of endothelial lipid transport in systemic energy balance remains unclear. Ghrelin conveys nutritional information through the central nervous system and increases adiposity, while deficiency in its receptor, growth hormone secretagogue-receptor (GHSR), suppresses adiposity on a high-fat diet. This study aims to examine the effect of ghrelin/GHSR signaling in the endothelium on lipid metabolism. Methods: We compared the effects of ghrelin on adiposity and lipid uptake into adipocytes in wild-type and GHSR-null mice. Transgenic mice expressing GHSR selectively in endothelial cells were also generated and compared with global GHSR-null and wild-type mice. The impact of ghrelin on lipid uptake-related genes was assessed in cultured endothelial cells. Results: Ghrelin increased adiposity and triglyceride clearance in wild-type but not in GHSR-null mice. GHSR-null mice showed higher serum triglyceride after olive oil gavage and lower white adipose tissue (WAT) weight on a high-fat diet, suggesting impaired lipid uptake. Restoring GHSR expression in endothelial cells increased lipoprotein lipase activity, lipid uptake into WAT, and WAT weight. Ghrelin enhanced free fatty acid uptake and the expression of lipid uptake genes in cultured endothelial cells, whereas these effects were absent in GHSR-null mice-derived endothelial cells. Knockdown of PPARγ revealed that ghrelin/GHSR signaling in endothelial cells promoted lipid uptake via endothelial PPARγ. Conclusions: Endothelial GHSR is key for regulating lipid metabolism via PPARγ in response to ghrelin and for the role of endothelium in regulating white adipocyte metabolism. Targeting endothelial ghrelin signaling may be a promising therapeutic approach for managing excessive adiposity and associated metabolic disorders.
Open AccessGhrelin Promotes Lipid Uptake into White Adipose Tissue via Endothelial Growth Hormone Secretagogue-Receptor in Mice
Background/Objectives: Endothelial peroxisome proliferator-activated receptor gamma (PPARγ) regulates adipose tissue by facilitating lipid uptake into white adipocytes, but the role of endothelial lipid transport in systemic energy balance remains unclear. Ghrelin conveys nutritional information through the central nervous system and increases adiposity, while deficiency in its receptor, growth hormone secretagogue-receptor (GHSR), suppresses adiposity on a high-fat diet. This study aims to examine the effect of ghrelin/GHSR signaling in the endothelium on lipid metabolism. Methods: We compared the effects of ghrelin on adiposity and lipid uptake into adipocytes in wild-type and GHSR-null mice. Transgenic mice expressing GHSR selectively in endothelial cells were also generated and compared with global GHSR-null and wild-type mice. The impact of ghrelin on lipid uptake-related genes was assessed in cultured endothelial cells. Results: Ghrelin increased adiposity and triglyceride clearance in wild-type but not in GHSR-null mice. GHSR-null mice showed higher serum triglyceride after olive oil gavage and lower white adipose tissue (WAT) weight on a high-fat diet, suggesting impaired lipid uptake. Restoring GHSR expression in endothelial cells increased lipoprotein lipase activity, lipid uptake into WAT, and WAT weight. Ghrelin enhanced free fatty acid uptake and the expression of lipid uptake genes in cultured endothelial cells, whereas these effects were absent in GHSR-null mice-derived endothelial cells. Knockdown of PPARγ revealed that ghrelin/GHSR signaling in endothelial cells promoted lipid uptake via endothelial PPARγ. Conclusions: Endothelial GHSR is key for regulating lipid metabolism via PPARγ in response to ghrelin and for the role of endothelium in regulating white adipocyte metabolism. Targeting endothelial ghrelin signaling may be a promising therapeutic approach for managing excessive adiposity and associated metabolic disorders.
- 2 July 2018
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 67 (2) , 312-313
Multinuclear and Ground Glass-Formed Cells Detected in the Peritoneal Dialysate
(See pages 311–2 for the Photo Quiz.)
- 2 July 2018
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 67 (2) , 312-313
Multinuclear and Ground Glass-Formed Cells Detected in the Peritoneal Dialysate
(See pages 311–2 for the Photo Quiz.)
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e295-e296
PS 08-11 THE EFFECT OF MINERALOCORTICOID ANTAGONIST ON RENAL INSULIN RESISTANCE AND THE PROGRESSION OF RENAL FAILURE IN NON-DIABETIC CKD PATIENTS
Insulin resistance (IR) is evident in Chronic Kidney Disease (CKD ) even in non-diabetic patient, although the clinical relevances remain to be determined. We reported that aldosterone increase in CKD is contributed to IR in CKD and MR antagonist, spironolactone ameliorated IR in CKD in three months treatment. We follow our CKD cohort for five years and explored the relevance of IR in the progression of CKD. We also performed procebo-controlled clinical trial using mineralocorticoid receptor antagonist eplerenone and examined its effects on the progression of CKD. Between 2007 and 2008, consecutive 197 patients with CKD were enrolled and followed these patients for five years. Risk factors for the progression of CKD evaluated by the rate of eGFR decline was determined by multiple regression analysis. We recruited the patients with hyperaldosterone and IR patients (N = 48) and treated them with eprelenone (N = 22) and placebo (N = 26) for three years and evaluated its effect on eGFR decline. In CKD patients, HOMA-IR levels were negatively associated with eGFR levels. Plasma aldosterone concentration was determined as an independent risk factor for HOMA-IR levels. After three years follow-up, baseline HOMA-IR levels was significantly associated with eGFR decline and selected as a independent risk factor. We classified quartile groups depending on the baseline HOMA-IR levels and found out the 3rd and 4th quartile groups were significantly higher decline in eGFR. Finally, eplereneone ameliorated eGFR decline of non-diabetic CKD patients with high HOMA-IR and high plasm aldosterone levels(eplerenone; eGFR 51.0 ± 3.7→50.4 ± 3.4 ml/min, placebo; eGFR 55.6 ± 5.1→53.1 ± 4.7 ml/min). IR is a risk factor of the progression of CKD and mineralocorticoid receptor antagonist will provide a novel strategy against the progression of CKD through the amelioration of IR.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e295-e296
PS 08-11 THE EFFECT OF MINERALOCORTICOID ANTAGONIST ON RENAL INSULIN RESISTANCE AND THE PROGRESSION OF RENAL FAILURE IN NON-DIABETIC CKD PATIENTS
Insulin resistance (IR) is evident in Chronic Kidney Disease (CKD ) even in non-diabetic patient, although the clinical relevances remain to be determined. We reported that aldosterone increase in CKD is contributed to IR in CKD and MR antagonist, spironolactone ameliorated IR in CKD in three months treatment. We follow our CKD cohort for five years and explored the relevance of IR in the progression of CKD. We also performed procebo-controlled clinical trial using mineralocorticoid receptor antagonist eplerenone and examined its effects on the progression of CKD. Between 2007 and 2008, consecutive 197 patients with CKD were enrolled and followed these patients for five years. Risk factors for the progression of CKD evaluated by the rate of eGFR decline was determined by multiple regression analysis. We recruited the patients with hyperaldosterone and IR patients (N = 48) and treated them with eprelenone (N = 22) and placebo (N = 26) for three years and evaluated its effect on eGFR decline. In CKD patients, HOMA-IR levels were negatively associated with eGFR levels. Plasma aldosterone concentration was determined as an independent risk factor for HOMA-IR levels. After three years follow-up, baseline HOMA-IR levels was significantly associated with eGFR decline and selected as a independent risk factor. We classified quartile groups depending on the baseline HOMA-IR levels and found out the 3rd and 4th quartile groups were significantly higher decline in eGFR. Finally, eplereneone ameliorated eGFR decline of non-diabetic CKD patients with high HOMA-IR and high plasm aldosterone levels(eplerenone; eGFR 51.0 ± 3.7→50.4 ± 3.4 ml/min, placebo; eGFR 55.6 ± 5.1→53.1 ± 4.7 ml/min). IR is a risk factor of the progression of CKD and mineralocorticoid receptor antagonist will provide a novel strategy against the progression of CKD through the amelioration of IR.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e275
ISH NIA PS 01-01 Ghrelin receptor in the endothelial cells regulates blood pressure and metabolic responses in mice
Ghrelin, a gastric derived peptide, reduces blood pressure and increases adiposity. We and others have reported that growth hormone secretagogue-receptor (GHSR) deficiency leads to high blood pressure and less adiposity compared to wild-type mice. Endothelial cells play roles in the adiposity by lipid uptake in white adipose tissue as well as in blood pressure. In this study, we examined the role of endogenous Ghrelin/GHSR in the endothelium in blood pressure and metabolic responses on high fat feeding. We generated transgenic mice expressing GHSR selectively in the endothelial cells (GHSR-EC mice) in the background of GHSR null mice by using Cre-LoxP system, and compared these mice with GHSR null mice and wild-type mice. Blood pressure was measured by tail cuff method. Serum free fatty acid (FFA) and triglyceride (TG) concentrations after olive oil gavage and the effect of high fat diet on weight gain were examined. GHSR-null mice showed increase in blood pressure compared to wild-type mice (142.1 ± 3.6 mmHg vs 126.7 ± 2.6 mmHg, p < 0.05). In GHSR-EC mice, blood pressure levels were 132.9 ± 2.6 mmHg, and there was not significant difference between GHSR-EC mice and wild-type mice. In GHSR-null mice, serum FFA and TG levels after olive oil gavage were significantly increased compared with wild-type mice. The weight of white adipose tissue was significantly decreased in GHSR-null mice treated with high fat diet, suggesting that lipid uptake is reduced in GHSR-null mice. Re-expressing of GHSR in endothelial cells in GHSR null mice restored lipid uptake in WAT and decreased serum lipid levels. These data suggest that Ghrelin/GHSR pathway in the endothelium play an important role of endothelial function and regulate blood pressure and metabolic responses.
- 1 September 2016
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 34 (Supplement) , e275
ISH NIA PS 01-01 Ghrelin receptor in the endothelial cells regulates blood pressure and metabolic responses in mice
Ghrelin, a gastric derived peptide, reduces blood pressure and increases adiposity. We and others have reported that growth hormone secretagogue-receptor (GHSR) deficiency leads to high blood pressure and less adiposity compared to wild-type mice. Endothelial cells play roles in the adiposity by lipid uptake in white adipose tissue as well as in blood pressure. In this study, we examined the role of endogenous Ghrelin/GHSR in the endothelium in blood pressure and metabolic responses on high fat feeding. We generated transgenic mice expressing GHSR selectively in the endothelial cells (GHSR-EC mice) in the background of GHSR null mice by using Cre-LoxP system, and compared these mice with GHSR null mice and wild-type mice. Blood pressure was measured by tail cuff method. Serum free fatty acid (FFA) and triglyceride (TG) concentrations after olive oil gavage and the effect of high fat diet on weight gain were examined. GHSR-null mice showed increase in blood pressure compared to wild-type mice (142.1 ± 3.6 mmHg vs 126.7 ± 2.6 mmHg, p < 0.05). In GHSR-EC mice, blood pressure levels were 132.9 ± 2.6 mmHg, and there was not significant difference between GHSR-EC mice and wild-type mice. In GHSR-null mice, serum FFA and TG levels after olive oil gavage were significantly increased compared with wild-type mice. The weight of white adipose tissue was significantly decreased in GHSR-null mice treated with high fat diet, suggesting that lipid uptake is reduced in GHSR-null mice. Re-expressing of GHSR in endothelial cells in GHSR null mice restored lipid uptake in WAT and decreased serum lipid levels. These data suggest that Ghrelin/GHSR pathway in the endothelium play an important role of endothelial function and regulate blood pressure and metabolic responses.
- Open Access
- 11 November 2015
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 187
A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis
Primary biliary cirrhosis (PBC) is an immune-mediated chronic cholestatic liver disease, characterized by increased concentrations of serum IgM and the presence of circulating anti-mitochondrial antibodies. Although bone diseases such as osteoporosis or osteodystrophy are commonly associated with PBC, osteomalacia which is caused by abnormal vitamin D metabolism, mineralization defects, and phosphate deficiency has not been recognized as a complication of PBC. We report the case of a 49-year-old Japanese woman who complained of multiple fractures. Hypophosphatemic osteomalacia was diagnosed from a low serum phosphorus level, 1,25-dihydroxyvitamin D3 level, high levels of bone specific alkaline phosphatase and the findings of bone scintigraphy, although a bone biopsy was not performed. Twenty four hour urine demonstrated a low renal fractional tubular reabsorption of phosphate, increased fractional excretion of uric acid and generalized aminoaciduria. An intravenous bicarbonate loading test suggested the presence of proximal renal tubular acidosis (RTA). These biochemical data indicated Fanconi syndrome with proximal RTA. A kidney biopsy demonstrated the features of tubulointerstitial nephritis (TIN). The patient was also suspected as having primary biliary cirrhosis (PBC) because of high levels of alkaline phosphatase, IgM and the presence of anti-mitochondrial M2 antibody, though biochemical liver function was normal. Sequential liver biopsy was compatible with PBC and the diagnosis of PBC was definite. After administration of 1,25 dihydroxyvitamin D3, neutral potassium phosphate, sodium bicarbonate for osteomalacia and subsequent predonizolone for TIN, symptoms of fractures were relieved and renal function including Fanconi syndrome was ameliorated. In this case, asymptomatic PBC was shown to induce TIN with Fanconi syndrome with dysregulation of electrolytes and vitamin D metabolism, which in turn led to osteomalacia with multiple fractures. Osteomalacia has not been recognized as a result of the renal involvement of PBC. PBC and its rare complication of TIN with Fanconi syndrome should be considered in adult patients with unexplained osteomalacia even in the absence of liver dysfunction.
- 11 November 2015
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 187
Open AccessA case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis
Primary biliary cirrhosis (PBC) is an immune-mediated chronic cholestatic liver disease, characterized by increased concentrations of serum IgM and the presence of circulating anti-mitochondrial antibodies. Although bone diseases such as osteoporosis or osteodystrophy are commonly associated with PBC, osteomalacia which is caused by abnormal vitamin D metabolism, mineralization defects, and phosphate deficiency has not been recognized as a complication of PBC. We report the case of a 49-year-old Japanese woman who complained of multiple fractures. Hypophosphatemic osteomalacia was diagnosed from a low serum phosphorus level, 1,25-dihydroxyvitamin D3 level, high levels of bone specific alkaline phosphatase and the findings of bone scintigraphy, although a bone biopsy was not performed. Twenty four hour urine demonstrated a low renal fractional tubular reabsorption of phosphate, increased fractional excretion of uric acid and generalized aminoaciduria. An intravenous bicarbonate loading test suggested the presence of proximal renal tubular acidosis (RTA). These biochemical data indicated Fanconi syndrome with proximal RTA. A kidney biopsy demonstrated the features of tubulointerstitial nephritis (TIN). The patient was also suspected as having primary biliary cirrhosis (PBC) because of high levels of alkaline phosphatase, IgM and the presence of anti-mitochondrial M2 antibody, though biochemical liver function was normal. Sequential liver biopsy was compatible with PBC and the diagnosis of PBC was definite. After administration of 1,25 dihydroxyvitamin D3, neutral potassium phosphate, sodium bicarbonate for osteomalacia and subsequent predonizolone for TIN, symptoms of fractures were relieved and renal function including Fanconi syndrome was ameliorated. In this case, asymptomatic PBC was shown to induce TIN with Fanconi syndrome with dysregulation of electrolytes and vitamin D metabolism, which in turn led to osteomalacia with multiple fractures. Osteomalacia has not been recognized as a result of the renal involvement of PBC. PBC and its rare complication of TIN with Fanconi syndrome should be considered in adult patients with unexplained osteomalacia even in the absence of liver dysfunction.
- Open Access
- 1 June 2012
- Published by Springer Nature in BMC Nephrology
- Vol. 13 (1) , 32
MPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report
Antineutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis (CGN) is a major cause of rapidly progressive glomerulonephritis (RPGN). ANCA-associated CGN is generally classified into pauci-immune RPGN, in which there are few or no immune complexes.
- 1 June 2012
- Published by Springer Nature in BMC Nephrology
- Vol. 13 (1) , 32
Open AccessMPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report
Antineutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis (CGN) is a major cause of rapidly progressive glomerulonephritis (RPGN). ANCA-associated CGN is generally classified into pauci-immune RPGN, in which there are few or no immune complexes.
- Open Access
- 14 December 2011
- Published by IntechOpen
Nephritis Associated with Ulcerative Colitis
Nephritis Associated with Ulcerative Colitis | InTechOpen, Published on: 2011-12-14. Authors: Hirobumi Tokuyama, Shu Wakino, Koichi Hayashi, et
- 14 December 2011
- Published by IntechOpen
Open AccessNephritis Associated with Ulcerative Colitis
Nephritis Associated with Ulcerative Colitis | InTechOpen, Published on: 2011-12-14. Authors: Hirobumi Tokuyama, Shu Wakino, Koichi Hayashi, et
- 25 May 2010
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 14 (5) , 483-486
Acute interstitial nephritis associated with ulcerative colitis
Although drugs used in inflammatory bowel diseases (IBD) cause renal injury, glomerulopathies may also accompany IBD. We report a case with the rare association of ulcerative colitis (UC) and acute progressive interstitial nephritis. Although the kidney is acknowledged as a target organ for injury as a result of drug nephrotoxicity, our findings lend support to the novel recognition that the deranged autoimmune system emerging in UC causes interstitial nephritis as an extraintestinal manifestation. Overt renal failure due to interstitial nephritis has rarely been reported in UC patients. The case presented here therefore provides novel information on UC-associated nephropathy.
- 25 May 2010
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 14 (5) , 483-486
Acute interstitial nephritis associated with ulcerative colitis
Although drugs used in inflammatory bowel diseases (IBD) cause renal injury, glomerulopathies may also accompany IBD. We report a case with the rare association of ulcerative colitis (UC) and acute progressive interstitial nephritis. Although the kidney is acknowledged as a target organ for injury as a result of drug nephrotoxicity, our findings lend support to the novel recognition that the deranged autoimmune system emerging in UC causes interstitial nephritis as an extraintestinal manifestation. Overt renal failure due to interstitial nephritis has rarely been reported in UC patients. The case presented here therefore provides novel information on UC-associated nephropathy.
- 1 September 2008
- Vol. 66 (9) , 1719-22
[Methodology for assessment of renal function].
A variety of methods for evaluation of renal function have been discovered, among which glomerular filtration rate (GFR) attracts much attention because of the major determinant of renal function. Recently, novel technique to evaluate glomerular filtration has been developed, including cystatin C, which reflects the changes in GFR at the earlier stage than serum creatinine. Furthermore, a progress has been made in evaluating tubular damage, with the discovery of N-acetyl glucosaminidase and liver-type fatty acid binding protein. More convenient and sensitive methods will be required to assess the changes in renal function in a clinical setting.
- 1 September 2008
- Vol. 66 (9) , 1719-22
[Methodology for assessment of renal function].
A variety of methods for evaluation of renal function have been discovered, among which glomerular filtration rate (GFR) attracts much attention because of the major determinant of renal function. Recently, novel technique to evaluate glomerular filtration has been developed, including cystatin C, which reflects the changes in GFR at the earlier stage than serum creatinine. Furthermore, a progress has been made in evaluating tubular damage, with the discovery of N-acetyl glucosaminidase and liver-type fatty acid binding protein. More convenient and sensitive methods will be required to assess the changes in renal function in a clinical setting.